isradipine has been researched along with Impotence in 1 studies
Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sooriyarachchi, MR | 1 |
| Whitehead, J | 1 |
| Matsushita, T | 1 |
| Bolland, K | 1 |
| Whitehead, A | 1 |
1 other study available for isradipine and Impotence
| Article | Year |
|---|---|
Incorporating data received after a sequential trial has stopped into the final analysis: implementation and comparison of methods.
Topics: Biometry; Calcium Channel Blockers; Clinical Trials as Topic; Data Interpretation, Statistical; Erec | 2003 |